Patent: 9,707,269
✉ Email this page to a colleague
Summary for Patent: 9,707,269
Title: | Sugar compositions for treating hemophilia A and/or von Willebrand disease |
Abstract: | The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen. |
Inventor(s): | Schulte; Stefan (Marburg, DE), Spirig; Rolf (Bern, CH), Zollner; Sabine (Muri, CH), Moses; Michael (Graevenwiesbach, DE), Wormsbaecher; Wilfried (Kirchhain, DE), Stoehr; Hans-Arnold (Wetter, DE) |
Assignee: | CSL BEHRING GMBH (Marburg, DE) |
Application Number: | 14/399,326 |
Patent Claims: | see list of patent claims |
Details for Patent 9,707,269
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Baxalta Us Inc. | VONVENDI | von willebrand factor (recombinant) | For Injection | 125577 | 12/08/2015 | ⤷ Try a Trial | 2032-05-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |